Header Logo

Connection

Andrew Ambrosy to Female

Back to Details
This is a "connection" page, showing publications Andrew Ambrosy has written about Female.
Andrew Ambrosy
Connection Strength
1.896
Female
  1. Worsening heart failure events in adults with mild-to-moderate chronic kidney disease. Am Heart J. 2026 Feb; 292:107290.
    View in: PubMed
    Score: 0.079
  2. Incidence of Heart Failure in Asian American, Native Hawaiian, and Other Pacific Islander Populations. J Am Coll Cardiol. 2025 Sep 09; 86(10):725-734.
    View in: PubMed
    Score: 0.079
  3. Inpatient Use of Guideline-Directed Medical Therapy During Heart?Failure Hospitalizations Among Community-Based Health Systems. JACC Heart Fail. 2025 Jan; 13(1):43-54.
    View in: PubMed
    Score: 0.074
  4. Analysis of Worsening Heart Failure Events in an Integrated Health Care System. J Am Coll Cardiol. 2022 Jul 12; 80(2):111-122.
    View in: PubMed
    Score: 0.063
  5. Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic. Clin Cardiol. 2022 Feb; 45(2):180-188.
    View in: PubMed
    Score: 0.061
  6. A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System. JAMA Netw Open. 2021 11 01; 4(11):e2135152.
    View in: PubMed
    Score: 0.060
  7. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
    View in: PubMed
    Score: 0.060
  8. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
    View in: PubMed
    Score: 0.057
  9. Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists. J Am Coll Cardiol. 2020 09 01; 76(9):1034-1048.
    View in: PubMed
    Score: 0.056
  10. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
    View in: PubMed
    Score: 0.054
  11. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. Am Heart J. 2018 05; 199:97-104.
    View in: PubMed
    Score: 0.047
  12. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Am J Cardiol. 2017 07 01; 120(1):98-105.
    View in: PubMed
    Score: 0.044
  13. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial. Am Heart J. 2017 Apr; 186:130-138.
    View in: PubMed
    Score: 0.043
  14. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. JACC Heart Fail. 2017 01; 5(1):1-13.
    View in: PubMed
    Score: 0.043
  15. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Circ Heart Fail. 2016 05; 9(5).
    View in: PubMed
    Score: 0.041
  16. The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2016 Mar; 18(3):306-13.
    View in: PubMed
    Score: 0.040
  17. Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure. Am J Cardiol. 2015 Apr 01; 115(7):938-41.
    View in: PubMed
    Score: 0.038
  18. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014 Apr 01; 63(12):1123-1133.
    View in: PubMed
    Score: 0.035
  19. The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care. 2013 Jun; 2(2):99-108.
    View in: PubMed
    Score: 0.034
  20. Not time to RELAX in acute heart failure. Lancet. 2013 May 25; 381(9880):1813.
    View in: PubMed
    Score: 0.034
  21. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013 Mar; 34(11):835-43.
    View in: PubMed
    Score: 0.033
  22. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. Am Heart J. 2013 Feb; 165(2):216-25.
    View in: PubMed
    Score: 0.033
  23. Capecitabine-induced chest pain relieved by diltiazem. Am J Cardiol. 2012 Dec 01; 110(11):1623-6.
    View in: PubMed
    Score: 0.032
  24. B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
    View in: PubMed
    Score: 0.031
  25. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012 Mar; 14(3):302-11.
    View in: PubMed
    Score: 0.031
  26. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018 05; 110:31-37.
    View in: PubMed
    Score: 0.023
  27. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175.
    View in: PubMed
    Score: 0.022
  28. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7.
    View in: PubMed
    Score: 0.021
  29. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
    View in: PubMed
    Score: 0.016
  30. A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19. Am Heart J. 2022 May; 247:76-89.
    View in: PubMed
    Score: 0.015
  31. Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ Open. 2022 01 31; 12(1):e048755.
    View in: PubMed
    Score: 0.015
  32. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022 04; 9(2):947-952.
    View in: PubMed
    Score: 0.015
  33. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Feb 05; 22(1):115.
    View in: PubMed
    Score: 0.014
  34. Loop Diuretic Use and Outcomes in Chronic Stable Heart Failure With Preserved Ejection Fraction-Reply. Mayo Clin Proc. 2021 02; 96(2):503-506.
    View in: PubMed
    Score: 0.014
  35. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.
    View in: PubMed
    Score: 0.014
  36. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation. JACC Cardiovasc Interv. 2020 10 26; 13(20):2331-2341.
    View in: PubMed
    Score: 0.014
  37. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7.
    View in: PubMed
    Score: 0.014
  38. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. JAMA Cardiol. 2020 06 01; 5(6):643-651.
    View in: PubMed
    Score: 0.014
  39. Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial. Circ Heart Fail. 2020 05; 13(5):e006758.
    View in: PubMed
    Score: 0.014
  40. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. Eur J Heart Fail. 2020 06; 22(6):1022-1031.
    View in: PubMed
    Score: 0.014
  41. Spontaneous Coronary Artery Dissection and Incident Ventricular Arrhythmias: Frequency, Clinical Characteristics, and Outcomes. JACC Cardiovasc Interv. 2020 02 24; 13(4):539-541.
    View in: PubMed
    Score: 0.013
  42. Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. JAMA Cardiol. 2020 02 01; 5(2):202-207.
    View in: PubMed
    Score: 0.013
  43. A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF). J Cardiovasc Transl Res. 2020 08; 13(4):540-548.
    View in: PubMed
    Score: 0.013
  44. Association between systolic ejection time and outcomes in heart failure by ejection fraction. Eur J Heart Fail. 2020 07; 22(7):1174-1182.
    View in: PubMed
    Score: 0.013
  45. Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019 12 01; 4(12):1280-1286.
    View in: PubMed
    Score: 0.013
  46. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.013
  47. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure? Am Heart J. 2020 02; 220:97-107.
    View in: PubMed
    Score: 0.013
  48. Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial. Eur J Heart Fail. 2019 11; 21(11):1472-1476.
    View in: PubMed
    Score: 0.013
  49. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 02 07; 380(6):539-548.
    View in: PubMed
    Score: 0.012
  50. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9.
    View in: PubMed
    Score: 0.012
  51. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 12 01; 193:124-130.
    View in: PubMed
    Score: 0.012
  52. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. ESC Heart Fail. 2018 12; 5(6):1035-1043.
    View in: PubMed
    Score: 0.012
  53. Improving Postdischarge Outcomes in Acute Heart Failure. Am J Ther. 2018 Jul/Aug; 25(4):e475-e486.
    View in: PubMed
    Score: 0.012
  54. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. Am Heart J. 2018 04; 198:145-151.
    View in: PubMed
    Score: 0.012
  55. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314.
    View in: PubMed
    Score: 0.011
  56. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail. 2018 02; 20(2):281-291.
    View in: PubMed
    Score: 0.011
  57. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039.
    View in: PubMed
    Score: 0.011
  58. Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial. Eur J Heart Fail. 2017 04; 19(4):552-562.
    View in: PubMed
    Score: 0.011
  59. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Circ Heart Fail. 2016 09; 9(9).
    View in: PubMed
    Score: 0.011
  60. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50.
    View in: PubMed
    Score: 0.010
  61. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. JACC Heart Fail. 2016 07; 4(7):580-588.
    View in: PubMed
    Score: 0.010
  62. Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry. J Cardiovasc Med (Hagerstown). 2016 Feb; 17(2):92-104.
    View in: PubMed
    Score: 0.010
  63. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. Am J Cardiol. 2016 Apr 01; 117(7):1144-50.
    View in: PubMed
    Score: 0.010
  64. Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations. Heart Fail Clin. 2015 Oct; 11(4):591-601.
    View in: PubMed
    Score: 0.010
  65. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial. Eur J Heart Fail. 2015 Oct; 17(10):1022-31.
    View in: PubMed
    Score: 0.010
  66. Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry. J Cardiovasc Med (Hagerstown). 2015 May; 16(5):331-40.
    View in: PubMed
    Score: 0.010
  67. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). Am J Cardiol. 2014 Dec 01; 114(11):1713-21.
    View in: PubMed
    Score: 0.009
  68. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail. 2014 May; 7(3):401-8.
    View in: PubMed
    Score: 0.009
  69. Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial). Am J Cardiol. 2013 Dec 01; 112(11):1763-9.
    View in: PubMed
    Score: 0.009
  70. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail. 2013 Dec; 15(12):1401-11.
    View in: PubMed
    Score: 0.008
  71. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013 Mar; 18(2):107-22.
    View in: PubMed
    Score: 0.008
  72. Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma. Dig Dis Sci. 2013 Sep; 58(9):2463-5.
    View in: PubMed
    Score: 0.008
  73. Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2013 Jan; 6(1):47-52.
    View in: PubMed
    Score: 0.008
  74. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. J Am Coll Cardiol. 2013 Feb 05; 61(5):571-9.
    View in: PubMed
    Score: 0.008
  75. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Am J Cardiol. 2013 Feb 15; 111(4):574-81.
    View in: PubMed
    Score: 0.008
  76. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. Am Heart J. 2012 Dec; 164(6):884-92.e2.
    View in: PubMed
    Score: 0.008
  77. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2012 Nov; 5(6):750-8.
    View in: PubMed
    Score: 0.008
  78. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. Eur J Heart Fail. 2013 Jan; 15(1):61-8.
    View in: PubMed
    Score: 0.008
  79. The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial. J Card Fail. 2012 Jul; 18(7):515-23.
    View in: PubMed
    Score: 0.008
  80. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012 May; 17(3):485-509.
    View in: PubMed
    Score: 0.008
  81. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown). 2011 Jul; 12(7):460-8.
    View in: PubMed
    Score: 0.007
  82. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J. 2011 Jul; 162(1):142-53.e1.
    View in: PubMed
    Score: 0.007
  83. Recurrent headaches in children: an epidemiological survey of two middle schools in inner city Chicago. Pain Pract. 2010 May-Jun; 10(3):214-21.
    View in: PubMed
    Score: 0.007
  84. Unilateral groin surgery in children: will the addition of an ultrasound-guided ilioinguinal nerve block enhance the duration of analgesia of a single-shot caudal block? Paediatr Anaesth. 2009 Sep; 19(9):892-8.
    View in: PubMed
    Score: 0.006
  85. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72.
    View in: PubMed
    Score: 0.006

© 2026 Kaiser Permanente

Your Privacy Choices